CGON
CG Oncology, Inc. Common stock
NASDAQ: CGON · HEALTHCARE · BIOTECHNOLOGY
$66.74
+3.07% today
Updated 2026-04-30
Market cap
$5.70B
P/E ratio
—
P/S ratio
1,410.56x
EPS (TTM)
$-2.08
Dividend yield
—
52W range
$21 – $74
Volume
1.3M
WallStSmart proprietary scores
32
out of 100
Grade: F
Strong Sell
Investment rating
8.0
Growth
A7.8
Quality
B+2.5
Profitability
F5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
20.6
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$87.86
+31.65%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
4 Strong Buy11 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Altman Z 20.61 — safe zone
+ Revenue growth 409.20% QoQ
Risks
- Thin margins at 0.00%
- Negative free cash flow $-36.22M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $191000.00 | $204000.00 | $1.14M | $4.04M | $4.04M |
| Net income | $-35.44M | $-48.61M | $-88.04M | $-161.00M | $-41.31M |
| EPS | — | — | — | — | $-2.08 |
| Free cash flow | $-29.82M | $-45.68M | $-78.95M | $-132.48M | $-36.22M |
| Profit margin | -18,556.54% | -23,826.96% | -7,729.50% | -3,985.02% | — |
Peer comparison
Smart narrative
CG Oncology, Inc. Common stock trades at $66.74. Our Smart Value Score of 32/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 20.61, it sits in the safe zone. TTM revenue stands at $4.04M.
Frequently asked questions
What is CG Oncology, Inc. Common stock's stock price?
CG Oncology, Inc. Common stock (CGON) trades at $66.74.
Is CG Oncology, Inc. Common stock overvalued?
Smart Value Score 32/100 (Grade F, Strong Sell).
What is the price target of CG Oncology, Inc. Common stock (CGON)?
The analyst target price is $87.86, representing +31.6% upside from the current price of $66.74.
What is CG Oncology, Inc. Common stock's revenue?
TTM revenue is $4.04M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
20.61 — safe zone.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1,410.56x
ROE-21.70%
Beta0.71
50D MA$64.61
200D MA$45.47
Shares out0.09B
Float0.07B
Short ratio—
Avg volume1.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—